Acrylic acid, monoester with propane-1,2-diol

Skin sensitisation

Administrative data

Endpoint:

skin sensitisation: in vivo (LLNA)

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2017

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)

GLP compliance:

yes (incl. QA statement)

Type of study:

mouse local lymph node assay (LLNA)

Test material

Test material information

Constituent 1

Reference substance name:

Acrylic acid, monoester with propane-1,2-diol

EC Number:

247-118-0

EC Name:

Acrylic acid, monoester with propane-1,2-diol

Cas Number:

25584-83-2

Molecular formula:

Unspecified

IUPAC Name:

1-hydroxypropan-2-yl prop-2-enoate 2-hydroxypropyl prop-2-enoate

Test material form:

liquid

Details on test material:

- State of aggregation: liquid/colorless, clear

In vivo test system

Test animals

Species:

mouse

Strain:

CBA/Ca

Sex:

female

Details on test animals and environmental conditions:

TEST ANIMALS
- Source: Envigo RMS B.V., Inc., Horst, The Netherlands
- Age at study initiation: 8 weeks
- Weight at study initiation: 17.0 - 21.0 g
- Housing: single housing (Polycarbonate cages type MII)
- Diet (e.g. ad libitum): Kliba mouse/rat maintenance diet “GLP”, supplied by Provimi Kliba SA, Kaiseraugst, Basel, Switzerland, ad libitum.
- Water (e.g. ad libitum): drinking water ad libitum
- Acclimation period: al least 5 days before the first application

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12/12

Study design: in vivo (LLNA)

Vehicle:

methyl ethyl ketone

Concentration:

1, 5 and 10% w/w

No. of animals per dose:

5

Details on study design:

The study comprised three treatment groups, a vehicle control group and a positive control group. Each group consisted of 5 mice. Epicutaneous application is simulating dermal contact with the compound which is possible to occur under practical use conditions. 25 µL per ear dorsal part of both ears. 3 consecutive application (day 0 – day 2) to the same application site. On study day five (about 66 to 72 hours after the last application of test substance to the ears) the mice were injected into a tail vein with 20 µCi of 3H-thymidine in 250 µL of sterile saline. The animals were sacrificed on study day 5 about 5 hours after 3H-thymidine injection by cervical dislocation under Isoflurane anesthesia. Immediately after the death of each animal a circular piece of tissue (diameter 0.8 cm) was punched out of the apical part of each ear of all animals. The weight of the pooled punches was determined for each animal. These measurements serve for detecting a potential inflammatory ear swelling. Immediately after removal of the ear punches the left and right auricular lymph nodes were dissected. The weight of the pooled lymph nodes from both sides was determined for each animal.

Positive control substance(s):

hexyl cinnamic aldehyde (CAS No 101-86-0)

Statistics:

3H-thymidine incorporation, cell count, lymph node weight and ear weight: WILCOXON - Test

Results and discussion

Positive control results:

A concurrent positive control with Alpha-Hexylcinnamaldehyde was included in this study. Additionally, studies using the positive control substance Alpha-Hexylcinnamaldehyde are performed twice a year in the laboratory in order to show that the test system is able to detect sensitizing compounds under the test conditions chosen (reliability check).

In vivo (LLNA)

Results

Parameter:

EC3

Value:

3.1

Any other information on results incl. tables

³H-thymidine incorporation, cell count and lymph node weight:

When applied as a 5% or 10% preparation in MEK, the test substance induced astatisticallysignificant increase of³H-thymidine incorporation into the cells from the auricular lymph nodes, which was above the cut off value forbiological relevance(increase above the cut off stimulation index (SI) of 3). The stimulation indices are 4.39 and 8.57 at 5% and 10%, respectively. Concomitantly, the increases in the auricular lymph node cell counts at 5% (SI = 1.68) and 10% (SI = 2.01) werestatistically significant and biologically relevant (above the cut-off value(increase to 1.5 fold or above of control value = stimulation index (SI)≥1.5). In addition, statistically significant increases in lymph node weights at 5% (Si = 1.43) and 10% (SI = 1.79) were noted. No relevant increase in either of above endpoints were observed at 1% preparation. The 15% HCA preparation in MEK induced a biologically relevant and statistically significant response in³H-thymidine incorporation (SI = 7.99) and lymph node cell counts (SI = 2.24) as well as statistically significant increased lymph node weights (SI = 2.05).

Ear weights:

The ear weight stimulation indices did not indicate any signs of relevant increase (SI≤ 1.25).

Test group	Tretment	³H-tymidine incorporation Stimulatin Index^1	Cell Count Stimulatin Index^1	Lymph Node Weight Stimulation Index^1	Ear Weight Stimulation Index^1
1	vehicle MEK	1.00	1.00	1.00	1.00
2	1% in MEK	1.41	1.02	0.98	1.00
3	5% in MEK	4.39##	1.68##	1.43##	1.00
4	10% in MEK	8.57##	2.01##	1.79##	1.01
5	positive control HCA 15% in MEK	7.99##	2.24##	2.05##	1.10##

¹test group x / test group 1 (vehicle control)

The statistical evaluations were performed using the Wilcoxon-test (# for p≤0.05, ## for p≤0.01)

Applicant's summary and conclusion

Interpretation of results:

Category 1B (indication of skin sensitising potential) based on GHS criteria

Conclusions:

Thus, it is concluded that Hydroxypropylacrylate exhibit a skin sensitizing potential in the Murine Local Lymph Node Assay under the test conditions chosen.